Jimmy Holder, MD, PhD
LabJan and Dan Duncan Neurological Research Institute1250 Moursund St., Suite 1350Houston, Texas 77030United States
- Texas Children’s Hospital, Clinical Care Center (Clinic)
- 6701 Fannin St. Ste 1250Houston, Texas 77030United States832-822-1750
- Jan and Dan Duncan Neurological Research Institute1250 Moursund St., Suite 1350Houston, Texas 77030United Statesholder@bcm.edu
Jacques L. Michaud , M.D.
Brain and Child Development
CHUSJ – Centre de Recherche
514 345-4931 #4727
Huganir laboratory - Richard L. Huganir , PhD
The Solomon H. Snyder Department of Neuroscience
Room: Hunterian 1001
Andrew Stanfield, PhD
The Patrick Wild Centre’s Co-director and Director of Clinical Research
The Patrick Wild Centre,
My research group carries out studies in two major areas: first, in testing potential therapeutic interventions for autism and intellectual disabilities and second, the study of brain mechanisms that underlie these conditions.
The focus of our clinical
Related to this work, my group is also involved in studies to identify the clinical,
In studying the brain mechanisms underlying autism and intellectual disability we employ a cognitive neuroscience approach and often using Magnetic Resonance Imaging scans to examine brain structure and function.
Gavin Rambaugh, PhD
Seth Grant, PhD
G2C::Genes to Cognition
Centre for Clinical Brain Sciences
The long-term aim is to understand the fundamental mechanisms of behaviour and how these mechanisms are involved in brain disease.
The research has focussed on the study of genes and proteins that control the synapses between nerve cells. Multiprotein machines comprising many different protein components are responsible for basic innate and learned behaviours and dysfunction in many brain diseases.
Recent work shows that these mechanisms are conserved between mice and humans opening new avenues for diagnosis and therapeutic discoveries. The Genes to Cognition programme has generated a large amount of data and tools that are freely available
Constance L. Smith-Hicks, M.D., Ph.D.
707 N. Broadway
Baltimore, MD 21205
Phone: (443) 923-2778
Dr. Smith-Hicks is a neurologist with special qualifications in child neurology and a research scientist at the Kennedy Krieger Institute. She is the Medical Director for the Center for Autism and Related Disorders, and the Director of Basic Science Research in Fragile X Syndrome at the Kennedy Krieger Institute. She co-directs the Fragile X, SYNGAP1
Dr. Smith-Hicks completed her Bachelors of Science degree in Biochemistry from the City College of New York (CUNY) and the Medical Scientist Training Program at Columbia University College of Physicians and Surgeons, where she obtained her M.D., Ph.D. in 2000. She trained in Pediatrics at the Albert Einstein College of Medicine and completed her Neurology and Pediatric Neurology training at the Johns Hopkins University School of Medicine in 2005. She then trained as a post-doctoral fellow in the Department of Neuroscience at Johns Hopkins University School of Medicine, under the guidance of Dr. Paul Worley and joined the faculty at Kennedy Krieger Institute in 2010.
She is a member of the Child Neurology Society, the Society for Neuroscience, and the American Academy of Neurology. She serves on several National Fragile X syndrome leadership teams and has served as a guest editor for several journals.
Dr. Smith-Hicks specializes in Autism Spectrum Disorder, Fragile X
Neuro-developmental disorders affecting learning and memory result from defective communication between neurons. Dr. Smith-Hicks’ team works to understand the process by which neurons are selected to integrate into networks. Her laboratory utilizes molecular, cell imagining, biochemical and electrophysiological techniques, as well as strategies that rely on the cellular reporting of active neurons from awake, behaving animals. She is interested in understanding the effect of imbalance of excitation and inhibition on the ability of neurons to integrate into stable networks. Her work is currently directed at understanding the mechanisms relevant to Fragile X Syndrome and Down syndrome and examines the impact of
Ingrid Scheffer AO MBBS PhD FRACP FAA FAES
Laureate Professor Ingrid Scheffer’s work has resulted in major paradigm shifts in epilepsy
Professor Scheffer is Chair of Paediatric Neurology Research at The University of Melbourne and Senior Principal Research Fellow at the Florey Institute of Neuroscience and Mental Health. Professor Scheffer is a founding fellow of the Australian Academy of Health and Medical Sciences and currently its Vice-President.
Ingrid and her colleagues have described a range of novel epilepsy syndromes beginning in infancy, childhood and adult life. Her work has meant that children and adults with sodium channel disorders such as Dravet syndrome and related epilepsies are diagnosed earlier and treated appropriately which improves their
In 2012, Professor Scheffer was awarded the L’Oréal-UNESCO Laureate for Women in Science for the Asia-Pacific
The L’Oréal-UNESCO Awards, which were first created in 1998,